Catalysts for Alembic Pharmaceuticals Inc
165 tracked
Dec 3, 2024
approval
BOSULIF (BOSUTINIB MONOHYDRATE) โ FDA approval
Alembic Pharmaceuticals Inc
โ
May 7, 2024
approval
BUPROPION HYDROCHLORIDE โ FDA approval
BUPROPION HYDROCHLORIDE
โ
Mar 21, 2024
approval
FLUOROURACIL โ FDA approval
Efudex
โ
Mar 21, 2024
approval
FLUOROURACIL โ FDA approval
Efudex
โ
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE โ FDA approval
duloxetine hydrochloride DR
โ
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE โ FDA approval
duloxetine hydrochloride DR
โ
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE โ FDA approval
duloxetine hydrochloride DR
โ
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE โ FDA approval
duloxetine hydrochloride DR
โ
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE โ FDA approval
duloxetine hydrochloride DR
โ
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE โ FDA approval
duloxetine hydrochloride DR
โ
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE โ FDA approval
duloxetine hydrochloride DR
โ
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE โ FDA approval
duloxetine hydrochloride DR
โ
Feb 8, 2024
approval
DULOXETINE HYDROCHLORIDE โ FDA approval
duloxetine hydrochloride DR
โ
Oct 18, 2023
approval
FLUOROURACIL โ FDA approval
Efudex
โ
Oct 3, 2023
approval
BUPROPION HYDROCHLORIDE โ FDA approval
BUPROPION HYDROCHLORIDE
โ
Oct 3, 2023
approval
BUPROPION HYDROCHLORIDE โ FDA approval
BUPROPION HYDROCHLORIDE
โ
Oct 3, 2023
approval
BUPROPION HYDROCHLORIDE โ FDA approval
BUPROPION HYDROCHLORIDE
โ
Sep 26, 2023
approval
BOSULIF (BOSUTINIB MONOHYDRATE) โ FDA approval
Alembic Pharmaceuticals Inc
โ
Sep 26, 2023
approval
BOSULIF (BOSUTINIB MONOHYDRATE) โ FDA approval
Alembic Pharmaceuticals Inc
โ
Aug 25, 2023
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) โ FDA approval
ALDACTAZIDE
โ
Aug 25, 2023
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) โ FDA approval
ALDACTAZIDE
โ
Jul 20, 2023
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) โ FDA approval
Alembic Pharmaceuticals Inc
โ
Apr 20, 2023
approval
BOSULIF (BOSUTINIB MONOHYDRATE) โ FDA approval
Alembic Pharmaceuticals Inc
โ
Mar 3, 2023
approval
FLUOROURACIL โ FDA approval
Efudex
โ
Jul 27, 2022
approval
LAMOTRIGINE โ FDA approval
Alembic Pharmaceuticals Inc
โ
Jul 27, 2022
approval
LAMOTRIGINE โ FDA approval
Alembic Pharmaceuticals Inc
โ
Jul 27, 2022
approval
LAMOTRIGINE โ FDA approval
Alembic Pharmaceuticals Inc
โ
Jun 10, 2022
approval
TIZANIDINE HYDROCHLORIDE โ FDA approval
TIZANIDINE HYDROCHLORIDE
โ
Jan 14, 2022
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) โ FDA approval
Alembic Pharmaceuticals Inc
โ
Jan 3, 2022
approval
DOXYCYCLINE HYCLATE โ FDA approval
DOXYCYCLINE HYCLATE
โ